NDC 50242-215
Xolair PFS
Omalizumab
Xolair PFS is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Genentech, Inc.. The primary component is Omalizumab.
Product ID | 50242-215_2c703552-8c5b-4c50-b673-507f12080a27 |
NDC | 50242-215 |
Product Type | Human Prescription Drug |
Proprietary Name | Xolair PFS |
Generic Name | Omalizumab |
Dosage Form | Injection, Solution |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2018-09-28 |
Marketing Category | BLA / BLA |
Application Number | BLA103976 |
Labeler Name | Genentech, Inc. |
Substance Name | OMALIZUMAB |
Active Ingredient Strength | 150 mg/mL |
Pharm Classes | Anti-IgE [EPC],Decreased IgE Activity [PE],IgE-directed Antibody Interactions [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |